When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

血管瘤

最后审阅: 21 Oct 2024
最后更新: 21 Mar 2023

小结

定义

病史和体格检查

关键诊断因素

  • 存在危险因素
  • 发生时间多变性
  • 粉色、红色或蓝色
  • 快速生长
  • 多变的压缩性
  • 扁平状或结节状
完整详情

其他诊断因素

  • 正常皮岛
  • 溃疡和出血
  • 温热
  • 低出生体重史
  • 多变的疼痛
  • 相关病变缺陷
  • 呈胡须分布和喘鸣
  • 腰骶部
  • 多处病变
  • 婴儿喂养不当,体重不增
  • 高输出性心力衰竭
完整详情

危险因素

  • 低出生体重
  • 早产儿
  • 白种人
  • 女性
  • 多胎妊娠
  • 高龄产妇
  • 绒毛取样
完整详情

诊断性检查

首要检查

  • 血管瘤的多普勒超声检查
完整详情

需考虑的检查

  • 血管瘤的 MRI 检查
  • 病灶活组织检查
完整详情

治疗流程

急症处理

无症状

合并功能障碍或外观缺陷

撰稿人

作者

Kari L. Martin, MD

Associate Professor of Dermatology & Child Health

Pediatric Dermatology

University of Missouri – Columbia

Columbia

MO

利益声明

KLM is an investigator in clinical trials with Scioderm, Lilly, and Durata; payments were received by her institution for these trials. None of these are relevant to this topic.

鸣谢

Dr Kari L. Martin would like to gratefully acknowledge Dr Tobian Muir, Dr Ingrid Polcari, Dr Annette Wagner, and Dr Carla T. Lee, the previous contributors to this topic.

利益声明

TM, IP, and CTL declare that they have no competing interests. AW: none disclosed.

同行评议者

Elena Pope, MD

Head

Department of Dermatology

The Hospital for Sick Children

Toronto

Ontario

Canada

利益声明

EP is an author of a number of references cited in this topic.

Elisabeth Higgins, MD

Consultant Dermatologist

King's College Hospital

London

UK

利益声明

EH declares that she has no competing interests.

Iona Friedan, MD

Professor of Clinical Dermatology and Pediatrics

University of California San Francisco

San Francisco

CA

利益声明

IF is a consultant for Pierre Fabre Dermatology, which is involved in clinical trials of propranolol for haemangiomas. IF is an author of a number of references cited in this topic.

内容使用需遵循免责声明